Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,600,831
-
Share change
-
-161,805
-
Total reported value
-
$15,941,000
-
Price per share
-
$6.13
-
Number of holders
-
25
-
Value change
-
-$991,957
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q1 2016
As of 31 Mar 2016,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,600,831 shares.
The largest 10 holders included
Sio Capital Management, LLC, Marshall Wace LLP, VANGUARD GROUP INC, BARD ASSOCIATES INC, Walleye Trading LLC, PURA VIDA INVESTMENTS, LLC, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, NORTHERN TRUST CORP, and BlackRock Fund Advisors.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.